Livalo Acute Myocardial Infarction Study (LAMIS)
NCT01265706 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2014-12-15
Summary
This study is performed to observe the incidence of major cardiovascular events in Korean patients with AMI after giving pitavastatin 2mg and 4mg longer than 1 year.
Conditions
- Acute Myocardial Infarction
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Young Jun Hong · Chonnam National University Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-07-31
- Primary Completion
- 2014-05-31
- Completion
- 2014-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Efficacy and Safety of Pitavastatin in a Real-world Setting
NCT04402112 ·Status: COMPLETED
-
Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)
NCT00549926 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome
NCT00640276 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib
NCT06314919 ·Status: RECRUITING
-
Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome
NCT02940366 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Atorvastatin and Pitavastatin on the Effect of HbA1c in AMI Patients With Abnormal Glucose Metabolism
NCT04945122 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Atorvastatin 10 mg Versus 40 mg in Eight Months Follow-up Coronary Flow Reserve and Bone Marrow Stem Cell Mobilization in Patients With Acute Myocardial Infarction
NCT00536887 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of PCSK9 Inhibitor on Retinal Microvessels in Patients With Coronary Heart Disease After Intensive Lipid-lowering Therapy
NCT05802108 ·Status: UNKNOWN ·Phase: PHASE4
-
Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention
NCT06281041 ·Status: COMPLETED
-
Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study
NCT00688922 ·Status: UNKNOWN ·Phase: PHASE4
-
Atorvastatin Mitigates WMH-Related Cognitive Impairment by Reducing VCAM-1
NCT07128212 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study Exploring Efficacy and Safety of Amlodipine in the Stented Angina Patients
NCT01120327 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS
NCT05624658 ·Status: RECRUITING ·Phase: NA
-
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
NCT05325034 ·Status: RECRUITING ·Phase: NA
-
Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention
NCT00610870 ·Status: COMPLETED ·Phase: NA
-
Statins and Risk of Myocardial Infarction in Real Life in France
NCT00679575 ·Status: COMPLETED
-
Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome
NCT01223586 ·Status: COMPLETED
-
Anfibatide Phase Ib-IIa Clinical Trial
NCT01585259 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intensive Statin Therapy in Patients With AMI
NCT01923077 ·Status: UNKNOWN ·Phase: PHASE2
-
Ezetimibe Utilization Early After Acute Myocardial Infarction, "EzAMI Trial"
NCT04701242 ·Status: RECRUITING ·Phase: NA
-
Effects of Pitavastatin on Insulin Sensitivity and Liver Fat
NCT02290106 ·Status: COMPLETED ·Phase: NA
-
Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)
NCT02069717 ·Status: WITHDRAWN
-
Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients
NCT02561845 ·Status: WITHDRAWN
-
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention (PCI) Study 2
NCT01058057 ·Status: UNKNOWN ·Phase: PHASE3
-
Statin and Post-interventional Coronary Microcirculation Dysfunction
NCT01751295 ·Status: UNKNOWN ·Phase: NA